In vitro and computational investigation of antioxidant and anticancer properties of Streptomyces coeruleofuscus SCJ extract on MDA-MB-468 triple-negative breast cancer cells.
Streptomyces coeruleofuscus
Anticancer activity
Antioxidant activity
HPLC-UV/vis
Pharmacokinetic properties
Triple-negative breast cancer
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
received:
15
03
2024
accepted:
11
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
This study aimed to explore the antioxidant potential of the ethyl acetate extract of Streptomyces coeruleofuscus SCJ strain, along with its inhibitory effects on the triple-negative human breast carcinoma cell line (MDA-MB-468). The ethyl acetate extract's total phenolic and flavonoid contents were quantified, and its antioxidant activity was investigated using DPPH (1,1-Diphenyl-2-picrylhydrazyl), ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid), and FRAP (Ferric Reducing Antioxidant Power) assays. Furthermore, the cytotoxic effect of the organic extract from Streptomyces coeruleofuscus SCJ on MDA-MB-468 cancer cells was assessed via the crystal violet assay. In tandem, a thorough computational investigation was conducted to explore the pharmacokinetic properties of the identified components of the extract, utilizing the SwissADME and pKCSM web servers. Additionally, the molecular interactions between these components and Estrogen Receptor Beta, identified as a potential target, were probed through molecular docking studies. The results revealed that ethyl acetate extract of SCJ strain exhibited remarkable antioxidant activity, with 39.899 ± 1.56% and 35.798 ± 0.082% scavenging activities against DPPH and ABTS, respectively, at 1 mg/mL. The extract also displayed significant ferric reducing power, with a concentration of 1.087 ± 0.026 mg ascorbic acid equivalents per mg of dry extract. Furthermore, a strong positive correlation (p < 0.0001) between the antioxidant activity, the polyphenol and the flavonoid contents. Regarding anticancer activity, the SCJ strain extract demonstrated significant anticancer activity against TNBC MDA-MB-468 cancer cells, with an inhibition percentage of 62.76 ± 0.62%, 62.67 ± 0.93%, and 58.07 ± 4.82% at 25, 50, and 100 µg/mL of the extract, respectively. The HPLC-UV/vis analysis revealed nine phenolic compounds: gallic acid, sinapic acid, p-coumaric acid, cinnamic acid, trans-fereulic acid, syringic acid, chloroqenic acid, ellagic acid, epicatechin. Streptomyces coeruleofuscus SCJ showed promise for drug discovery, exhibiting antioxidant and anticancer effects.
Identifiants
pubmed: 39448707
doi: 10.1038/s41598-024-76200-8
pii: 10.1038/s41598-024-76200-8
doi:
Substances chimiques
Antioxidants
0
Antineoplastic Agents
0
Flavonoids
0
Phenols
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
25251Informations de copyright
© 2024. The Author(s).
Références
Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. oxidative stress in Cancer. Cancer Cell. 38, 167–197 (2020).
pubmed: 32649885
pmcid: 7439808
doi: 10.1016/j.ccell.2020.06.001
Bardaweel, S. K. et al. Reactive oxygen species: the dual role in physiological and pathological conditions of the human body. Eurasian J. Med. 50, 193 (2018).
pubmed: 30515042
pmcid: 6263229
doi: 10.5152/eurasianjmed.2018.17397
Juan, C. A., de la Pérez, J. M., Plou, F. J. & Pérez-Lebeña, E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int. J. Mol. Sci. 22, 4642 (2021).
pubmed: 33924958
pmcid: 8125527
doi: 10.3390/ijms22094642
Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Prim. 5, 66 (2019).
pubmed: 31548545
doi: 10.1038/s41572-019-0111-2
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Calaf, G. M., Urzua, U., Termini, L. & Aguayo, F. Oxidative stress in female cancers. Oncotarget. 9, 23824 (2018).
pubmed: 29805775
pmcid: 5955122
doi: 10.18632/oncotarget.25323
Lee, J. H. et al. Archives of Biological SciencesArchives of Biological sciences. Nutr. Res. 43, 89–99 (2017).
pubmed: 28676202
doi: 10.1016/j.nutres.2017.05.013
Oshi, M. et al. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast Cancer Research and Treatment 194, 231–241 at (2022). https://doi.org/10.1007/s10549-022-06633-0
doi: 10.1007/s10549-022-06633-0
Yau, C. & Benz, C. C. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res. 10, 1–17 (2008).
doi: 10.1186/bcr2120
Zhou, C., Chen, H. Y., Chen, H. & Rui, W. Targeting cancer stem cells in cancer therapy. 1–30 doi: (2016). https://doi.org/10.2991/icmmbe-16.2016.17
Girish, C., Vijayalakshmi, P., Mentham, R., Rao, C. B. & Nama, S. Ch.Girish*et al Int J Pharm Bio Sci A REVIEW ON BREAST CANCER. Int. J. Pharm. Biol. Sci. 4, 2230–7605 (2014).
Liu, Y. et al. Advances in immunotherapy for triple-negative breast cancer. Mol. Cancer. 22, 1–27 (2023).
Park, S. Y., Choi, J. H. & Nam, J. S. Targeting cancer stem cells in triple-negative breast cancer. Cancers (Basel). 11, 965 (2019).
pubmed: 31324052
doi: 10.3390/cancers11070965
Milshteyn, A., Schneider, J. S. & Brady, S. F. Mining the metabiome: Identifying novel natural products from microbial communities. Chem. \& Biol. 21, 1211–1223 (2014).
doi: 10.1016/j.chembiol.2014.08.006
Rammali, S. et al. Antimicrobial and antioxidant activities of Streptomyces species from soils of three different cold sites in the Fez-Meknes region Morocco. Sci. Rep. 12, 1–22 (2022).
doi: 10.1038/s41598-022-21644-z
Kekuda, P., Onkarappa, R. & Jayanna, N. Characterization and antibacterial activity of a Glycoside Antibiotic from Streptomyces variabilis PO-178. Sci. Technol. Arts Res. J. 3, 116 (2015).
doi: 10.4314/star.v3i4.17
Labeda, D. P. et al. Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 101, 73–104 (2012).
doi: 10.1007/s10482-011-9656-0
LSooee, N. et al. Thirty complete Streptomyces genome sequences for mining novel secondary metabolite biosynthetic gene clusters. Sci. Data. 7, 1–9 (2020).
Jose, P. A., Maharshi, A. & Jha, B. Actinobacteria in natural products research: Progress and prospects. Microbiol. Res. 246, 126708 (2021).
pubmed: 33529791
doi: 10.1016/j.micres.2021.126708
Küçükgüzel, S., \cSenkarde\cs, S. & Güniz & Recent advances in bioactive pyrazoles. Eur. J. Med. Chem. 97, 786–815 (2015).
pubmed: 25555743
doi: 10.1016/j.ejmech.2014.11.059
Ho, Y. W. 5-(1-Pyrrolyl)-thieno [2, 3-d] pyrimidine as Building Block in Heterocyclic Synthesis: synthesis of some new 6-Substituted 5-(1-pyrrolyl)-thieno [2, 3-d] pyrimidines and 5 (4)-Substituted pyrimido-[2, 3: 4, 5] thieno [2, 3-e] pyrrolo [1, 2-a] pyrazine Der. Chem. Sci. Rev. Lett. (2012).
Basavanna, V., Ningaiah, S., Chandramouli, M., Sobha, A. & Doddamani, S. Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial. J. Iran. Chem. Soc. 18, 1479–1522 (2021).
doi: 10.1007/s13738-020-02152-1
RAHARJA, N. I. & Wahyudi, A. T. & others. Marine sponge-associated bacteria as biocontrol agents of vibriosis on whiteleg shrimp caused by Vibrio parahaemolyticus. Biodiversitas J. Biol. Divers. 20, (2019).
Aouiche, A. et al. Activité Antimicrobienne De Streptomyces sp. PAL111 d’origine saharienne contre divers microorganismes cliniques et toxinogènes résistants aux antibiotiques. J. Mycol. Med. 22, 42–51 (2012).
pubmed: 23177813
doi: 10.1016/j.mycmed.2011.12.077
Bensadón, S., Hervert-Hernández, D., Sáyago-Ayerdi, S. G. & Goñi, I. By-products of Opuntia ficus-indica as a source of antioxidant dietary fiber. Plant. Foods Hum. Nutr. 65, 210–216 (2010).
pubmed: 20623195
doi: 10.1007/s11130-010-0176-2
Bahorun, T. et al. Oxygen species scavenging activity of phenolic extracts from Hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung. 46, 1086–1089 (1996).
pubmed: 8955870
Blois, M. S. Comparison of different Organic solvents on antioxidant activity of Astaxanthin extracted from Hematococcus pluvialis. Nature. 181, 1199–1200 (1958).
doi: 10.1038/1811199a0
Blois, M. Antioxidant determinations by the Use of a stable free Radical. Nature. 181, 1199–1200 (1965).
doi: 10.1038/1811199a0
Re, R. et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol. Med. 26, 1231–1237 (1999).
pubmed: 10381194
doi: 10.1016/S0891-5849(98)00315-3
Oyaizu, M. Antioxidative activities of browning reaction prepared from glucosamine. Jpn J. Nutr. 44, 307–315 (1986).
doi: 10.5264/eiyogakuzashi.44.307
Feoktistova, M., Geserick & Leverkus, M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016, 343–346 (2016).
doi: 10.1101/pdb.prot087379
Younus, M. et al. Extracts of Euphorbia nivulia Buch.-Ham. Showed both phytotoxic and insecticidal capacities against Lemna minor L. and Oxycarenus Hyalinipennis Costa. PLoS One. 16, 1–14 (2021).
doi: 10.1371/journal.pone.0250118
Rammali, S. et al. Antimicrobial potential of Streptomyces coeruleofuscus SCJ isolated from microbiologically unexplored garden soil in Northwest Morocco. Sci. Rep. 1–16. https://doi.org/10.1038/s41598-024-53801-x (2024).
Cosconati, S. et al. Virtual screening with AutoDock: theory and practice. Expert Opin. Drug Discov. 5, 597–607 (2010).
pubmed: 21532931
pmcid: 3083070
doi: 10.1517/17460441.2010.484460
Lee, D. R. et al. Antioxidant activity and free radical scavenging activities of Streptomyces sp. strain MJM 10778. Asian Pac. J. Trop. Med. 7 12, 962–967 (2014).
doi: 10.1016/S1995-7645(14)60170-X
Yau, C. & Benz, C. C. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res. 10, R61 (2008).
pubmed: 18631401
pmcid: 2575534
doi: 10.1186/bcr2120
Ser, H. L. et al. Streptomyces antioxidans sp. nov., a novel mangrove soil actinobacterium with antioxidative and neuroprotective potentials. Front. Microbiol. 7, 1–14 (2016).
doi: 10.3389/fmicb.2016.00899
Ngo, D. H., Wijesekara, I., Vo, T. S., Van Ta, Q. & Kim, S. K. Marine food-derived functional ingredients as potential antioxidants in the food industry: an overview. Food Res. Int. 44, 523–529 (2011).
doi: 10.1016/j.foodres.2010.12.030
Cheng, C. et al. Ageloline A, new antioxidant and antichlamydial quinolone from the marine sponge-derived bacterium Streptomyces sp. SBT345. Tetrahedron Lett. 57, 2786–2789 (2016).
doi: 10.1016/j.tetlet.2016.05.042
Law, J. W. F. et al. Streptomyces monashensis sp. nov., a novel mangrove soil actinobacterium from East Malaysia with antioxidative potential. Sci. Rep. 9, 1–18 (2019).
doi: 10.1038/s41598-019-39592-6
Tan, L. T. H. et al. Streptomyces sp. MUM212 as a source of antioxidants with radical scavenging and metal chelating properties. Front. Pharmacol. 8, 276 (2017).
Narendhran, S., Rajiv, P., Vanathi, P. & Sivaraj, R. Innovare Academic sciences KUV39: Evaluation of antioxidant and cytotoxicity activity. Int. J. Pharm. Pharm. Sci. 6, 7–10 (2014).
Tan, L. T. H. et al. Investigation of antioxidative and anticancer potentials of Streptomyces sp. MUM256 isolated from Malaysia mangrove soil. Front. Microbiol. 6, (2015).
Law, J. W. F. et al. Streptomyces colonosanans sp. nov., a novel actinobacterium isolated from Malaysia mangrove soil exhibiting antioxidative activity and cytotoxic potential against human colon cancer cell lines. Front. Microbiol. 8, 1–15 (2017).
doi: 10.3389/fmicb.2017.00877
Rani, R., Arora, S., Kaur, J. & Manhas, R. K. Phenolic compounds as antioxidants and chemopreventive drugs from Streptomyces cellulosae strain TES17 isolated from rhizosphere of Camellia sinensis. BMC Complement. Altern. Med. 18, 1–15 (2018).
doi: 10.1186/s12906-018-2154-4
Gulcin Ilhami. Antioxidants and antioxidant methods: an updated overview. Arch. Toxicol. 94, 651–715 (2020).
pubmed: 32180036
doi: 10.1007/s00204-020-02689-3
Taechowisan, T., Samsawat, T., Puckdee, W. & Phutdhawong, W. S. Cytotoxicity and antibacterial activities of crude extract of Streptomyces sp. W08, an endophyte of Amomum Krervanh Pierre. J. Appl. Pharm. Sci. 11, 134–138 (2021).
Yip, W. K., Cheenpracha, S., Chang, L. C., Ho, C. C. & Seow, H. F. Anti-proliferative and anti-invasive properties of a purified fraction from Streptomyces sp. H7372. Int. J. Oncol. 37, 1229–1241 (2010).
pubmed: 20878070
Bieber, L. W. et al. The anthracyclinic complex retamycin, 1. Structure determination of the major constituents. J. Nat. Prod. 52, 385–388 (1989).
doi: 10.1021/np50062a029
Jongrungruangchok, S. et al. Identification of Streptomyces and Kitasatospora strains from Thai soils with geldanamycin production strain. Actinomycetologica. 20, 10–14 (2006).
doi: 10.3209/saj.20.10
Schulz, S. & Dickschat, J. S. Bacterial volatiles: The smell of small organisms. Nat. Prod. Rep. 24, 814–842 (2007).
pubmed: 17653361
doi: 10.1039/b507392h
Dickschat, J. S., Martens, T., Brinkhoff, T., Simon, M. & Schulz, S. Volatiles released by a Streptomyces species isolated from the North Sea. Chem. \& Biodivers. 2, 837–865 (2005).
doi: 10.1002/cbdv.200590062
Pollak, F. C. & Berger, R. G. Geosmin and related volatiles in bioreactor-cultured Streptomyces Citreus CBS 109.60. Appl. Environ. Microbiol. 62, 1295–1299 (1996).
pubmed: 16535293
pmcid: 1388831
doi: 10.1128/aem.62.4.1295-1299.1996
Gowdhaman, P., Antonyraj, K. & Annamalai, V. An effective approach on physical and dielectric properties of PZT- PVDF composites. Int. J. Adv. Sci. Res. 1, 322–328 (2015).
doi: 10.7439/ijasr.v1i8.2511
Ser, H. L. et al. Presence of antioxidative agent, Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro- in newly isolated Streptomyces mangrovisoli sp. nov. Front. Microbiol. 6, 1–11 (2015).
doi: 10.3389/fmicb.2015.00854
Kannabiran, K. Bioactivity of Pyrrolo [1, 2-a] pyrazine-1, 4-dione, hexahydro-3-(phenylmethyl)-Extracted from Streptomyces sp. VITPK9 isolated from the Salt Spring Habitat of Manipur, India. Asian J. Pharm. 10, (2016).
Gopi, M., Dhayanithi, N. B., Devi, K. N. & Kumar, T. T. A. Marine natural product, pyrrolo [-a] pyrazine–dione, hexahydro-(C7H10N2O2) of antioxidant properties from Bacillus species at Lakshadweep archipelago. J. Coast Life Med. 2, 632–637 (2014).
Fustero, S., Sanchez-Rosello, M., Barrio, P. & Simon-Fuentes, A. From 2000 to mid-2010: a fruitful decade for the synthesis of pyrazoles. Chem. Rev. 111, 6984–7034 (2011).
pubmed: 21806021
doi: 10.1021/cr2000459
Ansari, A., Ali, A. & Asif, M. & others. Biologically active pyrazole derivatives. New J. Chem. 41, 16–41 (2017).
doi: 10.1039/C6NJ03181A
Halliwell, B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs \& Aging. 18, 685–716 (2001).
doi: 10.2165/00002512-200118090-00004
Rahman, I. & Chung, S. Dietary polyphenols, deacetylases and chromatin remodeling in inflammation. Pers. Nutr. 101, 84–94 (2010).
doi: 10.1159/000314513
Yang, P., He, X. & Malhotra, A. Epigenetic targets of polyphenols in cancer. J. Environ. Pathol. Toxicol. Oncol. 33, (2014).
Velderrain-Rodríguez, G. R. et al. Gallic acid content and an antioxidant mechanism are responsible for the antiproliferative activity of ‘Ataulfo’ mango peel on LS180 cells. Molecules 23, (2018).
Mileo, A. M. & Miccadei, S. Polyphenols as modulator of oxidative stress in cancer disease: new therapeutic strategies. Oxid. Med. Cell. Longev. 6475624 (2016). (2016).
Lu, Y. et al. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur. J. Pharmacol. 641, 102–107 (2010).
pubmed: 20553913
pmcid: 3003697
doi: 10.1016/j.ejphar.2010.05.043
Pan, J. et al. Dimer and tetramer of gallic acid: facile synthesis, antioxidant and antiproliferative activities. Lett. Drug Des. \& Discov. 11, 27–32 (2014).
doi: 10.2174/15701808113109990032
Park, W. H. & Kim, S. H. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion. Oncol. Rep. 30, 513–519 (2013).
pubmed: 23660987
doi: 10.3892/or.2013.2447
Čižmáriková, M. et al. Ellagic Acid and Cancer Hallmarks: insights from experimental evidence. Biomolecules 13, (2023).
Vanella, L. et al. Apoptotic markers in a prostate cancer cell line: Effect of ellagic acid. Oncol. Rep. 30, 2804–2810 (2013).
pubmed: 24085108
doi: 10.3892/or.2013.2757
Balaji, C., Muthukumaran, J. & Nalini, N. Chemopreventive effect of sinapic acid on 1,2-dimethylhydrazine-induced experimental rat colon carcinogenesis. Hum. Exp. Toxicol. 33, 1253–1268 (2014).
pubmed: 24532707
doi: 10.1177/0960327114522501
Ero\uglu, C., Avc\i, E., Vural, H. & Kurar, E. Anticancer mechanism of sinapic acid in PC-3 and LNCaP human prostate cancer cell lines. Gene. 671, 127–134 (2018).
doi: 10.1016/j.gene.2018.05.049
Nagar, A. & India-, T. International journal of modern research and reviews original article influence of sinapic acid on induction of apoptosis in human laryngeal carcinoma cell LINE Department of Biochemistry, Bharathiar University, Coimbatore-641 046, Department of Bioche. 165–170 (2014).
Hameed, H., Aydin, S., Başaran, A. & Başaran, N. Assessment of cytotoxic properties of sinapic acid in vitro. Turkish J. Pharm. Sci. 13, 225–232 (2016).
Preeth, R. Green synthesis of copper oxide nanoparticles using sinapic acid: an underpinning step towards antiangiogenic therapy for breast cancer. J. Biol. Inorg. Chem. 24, 633–645 (2019).
doi: 10.1007/s00775-019-01676-z
Kampa, M. et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 6, 63–74 (2004).
doi: 10.1186/bcr752
Kanski, J., Aksenova, M., Stoyanova, A. & Butterfield, D. A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J. Nutr. Biochem. 13, 273–281 (2002).
pubmed: 12015157
doi: 10.1016/S0955-2863(01)00215-7
Hou, Y., Yang, J., Zhao, G. & Yuan, Y. Ferulic acid inhibits endothelial cell proliferation through NO down-regulating ERK1/2 pathway. J. Cell. Biochem. 93, 1203–1209 (2004).
pubmed: 15486966
doi: 10.1002/jcb.20281
Hudson, E. A., Dinh, P. A., Kokubun, T., Simmonds, M. S. J. & Gescher, A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol. Biomarkers \& Prev. 9, 1163–1170 (2000).
Jaganathan, S. K., Supriyanto, E. & Mandal, M. Events associated with apoptotic effect of p-Coumaric acid in HCT-15 colon cancer cells. World J. Gastroenterol. WJG. 19, 7726 (2013).
pubmed: 24282361
doi: 10.3748/wjg.v19.i43.7726
Pal, A., Tapadar, P. & Pal, R. Exploring the molecular mechanism of cinnamic acid-mediated cytotoxicity in Triple negative MDA-MB-231 breast Cancer cells. Anticancer Agents Med. Chem. 21, 1141–1150 (2020).
doi: 10.2174/1871520620666200807222248
Zhang, L., Liu, R. & Niu, W. Phytochemical and antiproliferative activity of proso millet. PLoS One 9, (2014).
Neuwirthová, J., Gál, B., Smilek, P. & Urbánková, P. Coffee in cancer chemoprevention. Klin. Onkol Cas Ces Slov. Onkol Spol. 30, 106–114 (2017).
Kono, Y. et al. Antioxidant activity of polyphenolics in diets: Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim. Biophys. Acta (BBA)-General Subj. 1335, 335–342 (1997).
doi: 10.1016/S0304-4165(96)00151-1
Dos Santos, M. D., Almeida, M. C., Lopes, N. P. & De Souza, G. E. P. evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull. 29, 2236–2240 (2006).
pubmed: 17077520
doi: 10.1248/bpb.29.2236
Zeng, A. et al. Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-κB signaling pathway. Oncol. Rep. 45, 717–727 (2021).
pubmed: 33416150
doi: 10.3892/or.2020.7891
Pérez-Durán, J. et al. –)-Epicatechin inhibits metastatic-Associated Proliferation, Migration, and Invasion of murine breast Cancer cells in Vitro. Molecules. 28, 1–13 (2023).
doi: 10.3390/molecules28176229
Moghtaderi, H., Sepehri, H., Delphi, L. & Attari, F. Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231. Bioimpacts. 8, 185–194 (2018).
pubmed: 30211078
pmcid: 6128975
doi: 10.15171/bi.2018.21
Fantini, M. et al. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment. Int. J. Mol. Sci. 16, 9236–9282 (2015).
pubmed: 25918934
pmcid: 4463587
doi: 10.3390/ijms16059236
Pires, D. E. V., Kaminskas, L. M. & Ascher, D. B. Prediction and optimization of pharmacokinetic and toxicity properties of the ligand. in Methods in Molecular Biology (eds Gore, M. & Jagtap, U.) vol. 1762 271–284 (Humana Press Inc., (2018).
Sellitto, A. et al. Insights into the role of Estrogen Receptor β in Triple-negative breast Cancer. Cancers 2020. 12, 1477 (2020).
Treeck, O., Schüler-Toprak, S. & Ortmann, O. Estrogen actions in Triple-negative breast Cancer. Cells. 9, 1–15 (2020).
doi: 10.3390/cells9112358
Kuiper, G. G. J. M. et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. Endocrinology. 139, 4252–4263 (1998).
pubmed: 9751507
doi: 10.1210/endo.139.10.6216
Mukherjee, S. & Majumder, D. Computational molecular docking assessment of hormone receptor adjuvant drugs: breast cancer as an example. Pathophysiology. 16, 19–29. https://doi.org/10.1016/j.pathophys.2008.12.001 (2009).
doi: 10.1016/j.pathophys.2008.12.001
pubmed: 19147336